Filters
Clonality
Type
Reactivity
Gene Name
Isotype
Host
Application
Clone
34 results for " Diabetes" - showing 1-34
Proinsulin, PI, ELISA Kit (Cat# AAA15108)
Full Name
Pig Proinsulin, PI ELISA Kit
Gene Names
INS; ILPR; IRDN; IDDM1; IDDM2; MODY10
Reactivity
Pig
Pricing
Standard Curve (Sample)
Insulin, ELISA Kit (Cat# AAA16899)
Full Name
Bovine Insulin ELISA Kit
Gene Names
INS; ILPR; IRDN; IDDM1; IDDM2; MODY10
Reactivity
Bovine
Pricing
Standard Curve (Sample)
Insulin (INS), ELISA Kit (Cat# AAA22467)
Full Name
Rat Insulin (INS) ELISA Kit
Gene Names
INS; ILPR; IRDN; IDDM1; IDDM2; MODY10
Reactivity
Rat
Pricing
Standard Curve (Sample)
Insulin (INS), ELISA Kit (Cat# AAA13170)
Full Name
Chicken Insulin (INS) ELISA Kit
Gene Names
INS; ILPR; IRDN; IDDM1; IDDM2; MODY10
Reactivity
Chicken
Pricing
Standard Curve (Sample)
Insulin, INS, ELISA Kit (Cat# AAA15329)
Full Name
Rat Insulin, INS ELISA Kit
Gene Names
INS; ILPR; IRDN; IDDM1; IDDM2; MODY10
Reactivity
Rat
Pricing
IHC (Immunohistochemistry)
(Immunohistochemistry-Phospho-PEA15-S104 pAb)
PEA15-S104, Polyclonal Antibody (Cat# AAA28302)
Full Name
Phospho-PEA15-S104 pAb
Gene Names
PEA15; PED; MAT1; HMAT1; MAT1H; PEA-15; HUMMAT1H; PED-PEA15; PED/PEA15
Reactivity
Human, Mouse, Rat
Applications
WB, IHC
Purity
Affinity Purification
Pricing
Standard Curve (Sample)
Insulin, ELISA Kit (Cat# AAA16879)
Full Name
Porcine Insulin ELISA Kit
Gene Names
INS; ILPR; IRDN; IDDM1; IDDM2; MODY10
Reactivity
Porcine
Pricing
Standard Curve (Sample)
Amylin, ELISA Kit (Cat# AAA12682)
Full Name
Human Amylin ELISA Kit
Gene Names
IAPP; DAP; IAP
Reactivity
Human
Pricing
Standard Curve (Sample)
Insulin, INS, ELISA Kit (Cat# AAA15237)
Full Name
Monkey Insulin, INS ELISA Kit
Gene Names
INS; ILPR; IRDN; IDDM1; IDDM2; MODY10
Reactivity
Monkey
Pricing
Standard Curve (Sample)
Insulin, INS, ELISA Kit (Cat# AAA15599)
Full Name
Fish Insulin, INS ELISA Kit
Gene Names
INS; ILPR; IRDN; IDDM1; IDDM2; MODY10
Reactivity
Fish
Pricing
Standard Curve (Sample)
Amylin, ELISA Kit (Cat# AAA16035)
Full Name
Human Amylin ELISA Kit
Gene Names
IAPP; DAP; IAP
Reactivity
Human
Pricing
Standard Curve (Sample)
insulin, ELISA Kit (Cat# AAA15583)
Full Name
Human Insulin, INS ELISA Kit
Gene Names
INS; ILPR; IRDN; IDDM1; IDDM2; MODY10
Reactivity
Human
Pricing
Standard Curve (Sample)
Insulin, ELISA Kit (Cat# AAA16412)
Full Name
Mouse Insulin ELISA Kit
Gene Names
INS; ILPR; IRDN; IDDM1; IDDM2; MODY10
Reactivity
Mouse
Pricing
Standard Curve (Sample)
Insulin, ELISA Kit (Cat# AAA16225)
Full Name
Rat Insulin ELISA Kit
Gene Names
INS; ILPR; IRDN; IDDM1; IDDM2; MODY10
Reactivity
Rat
Pricing
Sandwich ELISA
(Plate was coated with Glargine Insulin at 1.25 ug/ml in PBS, and then incubated with Anti-Glargine Insulin polyclonal antibody from 0.001 ug/ml to 0.5 ug/ml. The secondary antibody, HRP conjugated goat anti-Guinea pig IgG, were used at 1:6000 dilution.)
Glargine Insulin, Polyclonal Antibody (Cat# AAA28808)
Full Name
Anti-Glargine Insulin Polyclonal Antibody
Applications
EIA
Purity
This antibody is purified through a antigen affinity purification column, followed by dialysis against PBS.
Pricing
Standard Curve (Sample)
arginine vasopressin, ELISA Kit (Cat# AAA15151)
Full Name
Rat arginine vasopressin, AVP ELISA Kit
Gene Names
Avp; DI; VP; Vas
Reactivity
Rat
Pricing
FCM (Flow Cytometry)
(Flow cytometric analysis of 293 cells with SUMO4 antibody at 1/50 dilution (red) compared with an unlabelled control (cells without incubation with primary antibody; black). Alexa Fluor 488-conjugated goat anti rabbit IgG was used as the secondary antibody)
SUMO4, Monoclonal Antibody (Cat# AAA30248)
Full Name
SUMO4 Antibody
Gene Names
SUMO4; IDDM5; SMT3H4; SUMO-4; dJ281H8.4
Reactivity
Human, Mouse, Rat
Applications
WB, ICC, IF, IP, FC/FACS
Purity
ProA affinity purified
Pricing
IHC (Immunohistchemistry)
(Anti-ESRRG / ERR Gamma antibody IHC of human Skin, Melanoma. Immunohistochemistry of formalin-fixed, paraffin-embedded tissue after heat-induced antigen retrieval.)
ESRRG / ERR Gamma, Polyclonal Antibody (Cat# AAA12326)
Full Name
Rabbit Polyclonal to Human ESRRG / ERR Gamma
Gene Names
ESRRG; ERR3; NR3B3; ERRgamma
Reactivity
Gibbon, Bovine, Chicken, Dog, Gorilla, Hamster, Horse, Human, Monkey, Mouse, Orangutan, Pig, Rabbit, Rat
Predicted Reactivity: Bat, Xenopus, Zebrafish (at least 90% immunogen sequence identity)
Predicted Reactivity: Bat, Xenopus, Zebrafish (at least 90% immunogen sequence identity)
Applications
IHC - Paraffin
Purity
Immunoaffinity Purified
Pricing
WB (Western Blot)
(WB Suggested Anti-GNAS Antibody Titration: 1 ug/mlPositive Control: MCF-7 whole cell lysatesGNAS is strongly supported by BioGPS gene expression data to be expressed in Human MCF7 cells)
GNAS, Polyclonal Antibody (Cat# AAA23503)
Full Name
GNAS antibody - N-terminal region
Gene Names
GNAS; AHO; GSA; GSP; POH; GPSA; NESP; SCG6; SgVI; GNAS1; PITA3; C20orf45
Reactivity
Cow, Dog, Guinea Pig, Horse, Human, Mouse, Rabbit, Rat
Applications
IHC, WB
Purity
Affinity Purified
Pricing
SDS-PAGE
Islet Cell Autoantigen 1 (ICA1), Recombinant Protein (Cat# AAA20268)
Full Name
Recombinant Islet Cell Autoantigen 1 (ICA1)
Gene Names
ICA1; ICA69; ICAp69
Reactivity
Homo sapiens (Human)
Applications
WB
Purity
> 95%
Pricing
Application Data
(Published customer image: Histological staining of control and HBOT wounds at post-wounding days 7 and 29. A -D) H&E staining. E -H) CD34 immunohistochemistry. I+J) CD68 immunohistochemistry.From: uk B, Tong M, Fijneman EMG, van Neck JW (2014) Hyperbaric Oxygen Therapy to Treat Diabetes Impaired Wound Healing in Rats. PLoS ONE 9(10): e108533.)
CD68, Monoclonal Antibody (Cat# AAA12150)
Full Name
MOUSE ANTI RAT CD68:RPE
Applications
FC/FACS
Pricing
Application Data
(Published customer image: Histological staining of control and HBOT wounds at post-wounding days 7 and 29. A -D) H&E staining. E -H) CD34 immunohistochemistry. I+J) CD68 immunohistochemistry.From: uk B, Tong M, Fijneman EMG, van Neck JW (2014) Hyperbaric Oxygen Therapy to Treat Diabetes Impaired Wound Healing in Rats. PLoS ONE 9(10): e108533.)
CD68, Monoclonal Antibody (Cat# AAA12149)
Full Name
MOUSE ANTI RAT CD68
Applications
FC/FACS, IF, IP
Pricing
Application Data
(Published customer image: Histological staining of control and HBOT wounds at post-wounding days 7 and 29. A -D) H&E staining. E -H) CD34 immunohistochemistry. I+J) CD68 immunohistochemistry.From: uk B, Tong M, Fijneman EMG, van Neck JW (2014) Hyperbaric Oxygen Therapy to Treat Diabetes Impaired Wound Healing in Rats. PLoS ONE 9(10): e108533.)
CD68, Monoclonal Antibody (Cat# AAA12147)
Full Name
MOUSE ANTI RAT CD68:Biotin
Applications
FC/FACS
Pricing
Application Data
(Published customer image: Histological staining of control and HBOT wounds at post-wounding days 7 and 29. A -D) H&E staining. E -H) CD34 immunohistochemistry. I+J) CD68 immunohistochemistry.From: uk B, Tong M, Fijneman EMG, van Neck JW (2014) Hyperbaric Oxygen Therapy to Treat Diabetes Impaired Wound Healing in Rats. PLoS ONE 9(10): e108533.)
CD68, Monoclonal Antibody (Cat# AAA12151)
Full Name
MOUSE ANTI RAT CD68
Applications
FC/FACS, IF, IP, RIA, WB
Pricing
Application Data
(Published customer image: Histological staining of control and HBOT wounds at post-wounding days 7 and 29. A -D) H&E staining. E -H) CD34 immunohistochemistry. I+J) CD68 immunohistochemistry.From: uk B, Tong M, Fijneman EMG, van Neck JW (2014) Hyperbaric Oxygen Therapy to Treat Diabetes Impaired Wound Healing in Rats. PLoS ONE 9(10): e108533.)
CD68, Monoclonal Antibody (Cat# AAA12148)
Full Name
MOUSE ANTI RAT CD68:FITC
Applications
FC/FACS
Pricing
Application Data
(Published customer image: Leukocyte infiltration in COX-2-M/-M and COX-2+/+ mice. MPO enzymatic activity (panel A) was statistically similar in COX-2-M/-M and COX-2+/+ livers at 6 h and 24 h post-IRI. Ly-6G+ neutrophil (panel B) and granulocyte (panel C) infiltration were also comparable in COX-2-M/-M and COX-2+/+ livers after IRI. Mac-1+ (panel D) and CD68 (panel E) infiltrating macrophages were significantly reduced in COX-2-M/-M livers at 24 h post-reperfusion, but were statistically indistinguishable in COX-2-M/-M and COX-2+/+ livers at 6 h after IRI. No statistical differences in MMP-9 expression (panel F) could be demonstrated in livers of COX-2-M/-M and COX-2+/+ mice post-IRI. Representative immunostaining (panel G) of infiltrating Ly-6G+ (a,b,e,f) and Mac-1+ (c,d,g,h) leukocytes in livers of COX-2+/+ (a,c,e,g) and COX-2-M/-M (b,d,f,h) mice at 6 h (a to d) and 24 h (e to h) post IRI; (n = 5 -6/group; * indicates p)
CD68, Monoclonal Antibody (Cat# AAA12104)
Full Name
RAT ANTI MOUSE CD68:Biotin
Gene Names
Cd68; Lamp4; gp110; Scard1
Applications
FC/FACS
Pricing
Application Data
(Published customer image: Leukocyte infiltration in COX-2-M/-M and COX-2+/+ mice. MPO enzymatic activity (panel A) was statistically similar in COX-2-M/-M and COX-2+/+ livers at 6 h and 24 h post-IRI. Ly-6G+ neutrophil (panel B) and granulocyte (panel C) infiltration were also comparable in COX-2-M/-M and COX-2+/+ livers after IRI. Mac-1+ (panel D) and CD68 (panel E) infiltrating macrophages were significantly reduced in COX-2-M/-M livers at 24 h post-reperfusion, but were statistically indistinguishable in COX-2-M/-M and COX-2+/+ livers at 6 h after IRI. No statistical differences in MMP-9 expression (panel F) could be demonstrated in livers of COX-2-M/-M and COX-2+/+ mice post-IRI. Representative immunostaining (panel G) of infiltrating Ly-6G+ (a,b,e,f) and Mac-1+ (c,d,g,h) leukocytes in livers of COX-2+/+ (a,c,e,g) and COX-2-M/-M (b,d,f,h) mice at 6 h (a to d) and 24 h (e to h) post IRI; (n = 5 -6/group; * indicates p)
CD68, Monoclonal Antibody (Cat# AAA12108)
Full Name
RAT ANTI MOUSE CD68:RPE
Gene Names
Cd68; Lamp4; gp110; Scard1
Applications
FC/FACS
Pricing
Application Data
(Published customer image: Leukocyte infiltration in COX-2-M/-M and COX-2+/+ mice. MPO enzymatic activity (panel A) was statistically similar in COX-2-M/-M and COX-2+/+ livers at 6 h and 24 h post-IRI. Ly-6G+ neutrophil (panel B) and granulocyte (panel C) infiltration were also comparable in COX-2-M/-M and COX-2+/+ livers after IRI. Mac-1+ (panel D) and CD68 (panel E) infiltrating macrophages were significantly reduced in COX-2-M/-M livers at 24 h post-reperfusion, but were statistically indistinguishable in COX-2-M/-M and COX-2+/+ livers at 6 h after IRI. No statistical differences in MMP-9 expression (panel F) could be demonstrated in livers of COX-2-M/-M and COX-2+/+ mice post-IRI. Representative immunostaining (panel G) of infiltrating Ly-6G+ (a,b,e,f) and Mac-1+ (c,d,g,h) leukocytes in livers of COX-2+/+ (a,c,e,g) and COX-2-M/-M (b,d,f,h) mice at 6 h (a to d) and 24 h (e to h) post IRI; (n = 5 -6/group; * indicates p)
CD68, Monoclonal Antibody (Cat# AAA12105)
Full Name
RAT ANTI MOUSE CD68:FITC
Gene Names
Cd68; Lamp4; gp110; Scard1
Applications
FC/FACS
Pricing
Application Data
(Published customer image: Leukocyte infiltration in COX-2-M/-M and COX-2+/+ mice. MPO enzymatic activity (panel A) was statistically similar in COX-2-M/-M and COX-2+/+ livers at 6 h and 24 h post-IRI. Ly-6G+ neutrophil (panel B) and granulocyte (panel C) infiltration were also comparable in COX-2-M/-M and COX-2+/+ livers after IRI. Mac-1+ (panel D) and CD68 (panel E) infiltrating macrophages were significantly reduced in COX-2-M/-M livers at 24 h post-reperfusion, but were statistically indistinguishable in COX-2-M/-M and COX-2+/+ livers at 6 h after IRI. No statistical differences in MMP-9 expression (panel F) could be demonstrated in livers of COX-2-M/-M and COX-2+/+ mice post-IRI. Representative immunostaining (panel G) of infiltrating Ly-6G+ (a,b,e,f) and Mac-1+ (c,d,g,h) leukocytes in livers of COX-2+/+ (a,c,e,g) and COX-2-M/-M (b,d,f,h) mice at 6 h (a to d) and 24 h (e to h) post IRI; (n = 5 -6/group; * indicates p)
CD68, Monoclonal Antibody (Cat# AAA12109)
Full Name
RAT ANTI MOUSE CD68:RPE
Gene Names
Cd68; Lamp4; gp110; Scard1
Applications
FC/FACS
Pricing
Application Data
(Published customer image: Leukocyte infiltration in COX-2-M/-M and COX-2+/+ mice. MPO enzymatic activity (panel A) was statistically similar in COX-2-M/-M and COX-2+/+ livers at 6 h and 24 h post-IRI. Ly-6G+ neutrophil (panel B) and granulocyte (panel C) infiltration were also comparable in COX-2-M/-M and COX-2+/+ livers after IRI. Mac-1+ (panel D) and CD68 (panel E) infiltrating macrophages were significantly reduced in COX-2-M/-M livers at 24 h post-reperfusion, but were statistically indistinguishable in COX-2-M/-M and COX-2+/+ livers at 6 h after IRI. No statistical differences in MMP-9 expression (panel F) could be demonstrated in livers of COX-2-M/-M and COX-2+/+ mice post-IRI. Representative immunostaining (panel G) of infiltrating Ly-6G+ (a,b,e,f) and Mac-1+ (c,d,g,h) leukocytes in livers of COX-2+/+ (a,c,e,g) and COX-2-M/-M (b,d,f,h) mice at 6 h (a to d) and 24 h (e to h) post IRI; (n = 5 -6/group; * indicates p)
CD68, Monoclonal Antibody (Cat# AAA12102)
Full Name
RAT ANTI MOUSE CD68
Gene Names
Cd68; Lamp4; gp110; Scard1
Applications
FC/FACS, IF, IP, WB
Pricing
Application Data
(Published customer image: Leukocyte infiltration in COX-2-M/-M and COX-2+/+ mice. MPO enzymatic activity (panel A) was statistically similar in COX-2-M/-M and COX-2+/+ livers at 6 h and 24 h post-IRI. Ly-6G+ neutrophil (panel B) and granulocyte (panel C) infiltration were also comparable in COX-2-M/-M and COX-2+/+ livers after IRI. Mac-1+ (panel D) and CD68 (panel E) infiltrating macrophages were significantly reduced in COX-2-M/-M livers at 24 h post-reperfusion, but were statistically indistinguishable in COX-2-M/-M and COX-2+/+ livers at 6 h after IRI. No statistical differences in MMP-9 expression (panel F) could be demonstrated in livers of COX-2-M/-M and COX-2+/+ mice post-IRI. Representative immunostaining (panel G) of infiltrating Ly-6G+ (a,b,e,f) and Mac-1+ (c,d,g,h) leukocytes in livers of COX-2+/+ (a,c,e,g) and COX-2-M/-M (b,d,f,h) mice at 6 h (a to d) and 24 h (e to h) post IRI; (n = 5 -6/group; * indicates p)
CD68, Monoclonal Antibody (Cat# AAA12106)
Full Name
RAT ANTI MOUSE CD68:FITC
Gene Names
Cd68; Lamp4; gp110; Scard1
Applications
FC/FACS
Pricing
Application Data
(Published customer image: Leukocyte infiltration in COX-2-M/-M and COX-2+/+ mice. MPO enzymatic activity (panel A) was statistically similar in COX-2-M/-M and COX-2+/+ livers at 6 h and 24 h post-IRI. Ly-6G+ neutrophil (panel B) and granulocyte (panel C) infiltration were also comparable in COX-2-M/-M and COX-2+/+ livers after IRI. Mac-1+ (panel D) and CD68 (panel E) infiltrating macrophages were significantly reduced in COX-2-M/-M livers at 24 h post-reperfusion, but were statistically indistinguishable in COX-2-M/-M and COX-2+/+ livers at 6 h after IRI. No statistical differences in MMP-9 expression (panel F) could be demonstrated in livers of COX-2-M/-M and COX-2+/+ mice post-IRI. Representative immunostaining (panel G) of infiltrating Ly-6G+ (a,b,e,f) and Mac-1+ (c,d,g,h) leukocytes in livers of COX-2+/+ (a,c,e,g) and COX-2-M/-M (b,d,f,h) mice at 6 h (a to d) and 24 h (e to h) post IRI; (n = 5 -6/group; * indicates p)
CD68, Monoclonal Antibody (Cat# AAA12103)
Full Name
RAT ANTI MOUSE CD68:Biotin
Gene Names
Cd68; Lamp4; gp110; Scard1
Applications
FC/FACS
Pricing
Application Data
(Published customer image: Leukocyte infiltration in COX-2-M/-M and COX-2+/+ mice. MPO enzymatic activity (panel A) was statistically similar in COX-2-M/-M and COX-2+/+ livers at 6 h and 24 h post-IRI. Ly-6G+ neutrophil (panel B) and granulocyte (panel C) infiltration were also comparable in COX-2-M/-M and COX-2+/+ livers after IRI. Mac-1+ (panel D) and CD68 (panel E) infiltrating macrophages were significantly reduced in COX-2-M/-M livers at 24 h post-reperfusion, but were statistically indistinguishable in COX-2-M/-M and COX-2+/+ livers at 6 h after IRI. No statistical differences in MMP-9 expression (panel F) could be demonstrated in livers of COX-2-M/-M and COX-2+/+ mice post-IRI. Representative immunostaining (panel G) of infiltrating Ly-6G+ (a,b,e,f) and Mac-1+ (c,d,g,h) leukocytes in livers of COX-2+/+ (a,c,e,g) and COX-2-M/-M (b,d,f,h) mice at 6 h (a to d) and 24 h (e to h) post IRI; (n = 5 -6/group; * indicates p)
CD68, Monoclonal Antibody (Cat# AAA12107)
Full Name
RAT ANTI MOUSE CD68
Gene Names
Cd68; Lamp4; gp110; Scard1
Applications
FC/FACS, IF, IP, WB
Purity
Purified
Purified IgG - liquid
Purified IgG - liquid
Pricing
Application Data
(Published customer image: Leukocyte infiltration in COX-2-M/-M and COX-2+/+ mice. MPO enzymatic activity (panel A) was statistically similar in COX-2-M/-M and COX-2+/+ livers at 6 h and 24 h post-IRI. Ly-6G+ neutrophil (panel B) and granulocyte (panel C) infiltration were also comparable in COX-2-M/-M and COX-2+/+ livers after IRI. Mac-1+ (panel D) and CD68 (panel E) infiltrating macrophages were significantly reduced in COX-2-M/-M livers at 24 h post-reperfusion, but were statistically indistinguishable in COX-2-M/-M and COX-2+/+ livers at 6 h after IRI. No statistical differences in MMP-9 expression (panel F) could be demonstrated in livers of COX-2-M/-M and COX-2+/+ mice post-IRI. Representative immunostaining (panel G) of infiltrating Ly-6G+ (a,b,e,f) and Mac-1+ (c,d,g,h) leukocytes in livers of COX-2+/+ (a,c,e,g) and COX-2-M/-M (b,d,f,h) mice at 6 h (a to d) and 24 h (e to h) post IRI; (n = 5 -6/group; * indicates p)
CD68, Monoclonal Antibody (Cat# AAA12110)
Full Name
RAT ANTI MOUSE CD68
Gene Names
Cd68; Lamp4; gp110; Scard1
Applications
FC, IA, IF, IP, WB
Pricing